Functional polymorphisms of the glutathione S-transferases (GSTs) genes likely cause differential expression of the cisplatin-detoxifying enzymes, consequently rendering TCS suspcetible to varying degrees of cisplatin-induced hearing impairment. The gene discussed is HPGDS; the disease is hearing loss disorder.